CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
In summary, standard of care postoperative chemoradiation for patients with newly diagnosed GBM does not routinely provide durable local con...
Phase 4
Scottsdale, Arizona, United States and 11 other locations
The purpose of the this study is to see if the use of a PET scan with 18F-fluciclovine (PET or Fluciclovine PET) in addition to the normal radiation...
Phase 2
Phoenix, Arizona, United States
with or without epacadostat in the treatment of recurrent glioblastoma (GBM). The investigators hypothesize that this combination p...
Phase 2
Phoenix, Arizona, United States and 3 other locations
OKN-007 combined with temozolomide(TMZ) in patients with recurrent glioblastoma(GBM). All patients will have been previously treate...
Phase 2
Phoenix, Arizona, United States and 12 other locations
This trial is an open-label, multicenter, Phase 0/2 trial that will enroll up to 50 participants with recurrent glioblastoma which are sched...
Early Phase 1
Phoenix, Arizona, United States and 2 other locations
To test the effectiveness and safety of Optune® given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM...
Phoenix, Arizona, United States and 132 other locations
(TMZ) in adult participants with newly-diagnosed, MGMT unmethylated glioblastoma multiforme (GBM). The main questions it aims to an...
Phase 3
Phoenix, Arizona, United States
This is an open-label, multi-center Phase 0 study with an expansion phase that will enroll up to 24 participants with newly-diagnosed glioblastoma...
Early Phase 1
Phoenix, Arizona, United States and 1 other location
progression-free survival (PFS) of patients with newly diagnosed glioblastoma multiforme (GBM) can be improved by the addition of i...
Phase 3
Phoenix, Arizona, United States and 18 other locations
Clinical trials
Research sites
Resources
Legal